New Developments in Hodgkin's Lymphoma, An Issue of Hematology/Oncology Clinics of North America

1 Edición, Volumen 40-2 - 23 de marzo de 2026
Última edición
Editores: Alex F. Herrera, Alison J. Moskowitz
Idioma: Inglés

In this issue of Hematology/Oncology Clinics, guest editors Drs. Alex F. Herrera and Alison J. Moskowitz bring their considerable expertise to the topic of New Developme… Leer más

Descripción

In this issue of Hematology/Oncology Clinics, guest editors Drs. Alex F. Herrera and Alison J. Moskowitz bring their considerable expertise to the topic of New Developments in Hodgkin's Lymphoma. Top experts focus on how advances in our understanding of Hodgkin’s lymphoma biology, diagnostics, and novel therapies have revolutionized the management of Hodgkin’s lymphoma.

Puntos claves

Contains 13 relevant, practice-oriented topics including updates in our understanding of the biology of classic Hodgkin’s lymphoma; new standards in advanced stage Hodgkin’s lymphoma: selecting a novel regimen; adolescents and young adults with Hodgkin’s lymphoma; management of classic Hodgkin’s lymphoma in pregnancy; health disparities in classic Hodgkin’s lymphoma; and more
Provides in-depth clinical reviews on new developments in Hodgkin's lymphoma, offering actionable insights for clinical practice
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews

De interès para

Hematology/oncology

Índice

Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime?
Early-Stage Hodgkin Lymphoma: Time for Novel Agents?
New Standards in Advanced-stage Hodgkin Lymphoma: Selecting a Novel Regimen
Classic Hodgkin Lymphoma in the Older Adult: What’s New?
Management of Classic Hodgkin Lymphoma in Pregnancy
New Developments in Hodgkin’s Lymphoma: Outcomes and Disparities in Classic Hodgkin Lymphoma
The Modern Role of Radiation Therapy in Classic Hodgkin Lymphoma
Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies
The Role of Stem Cell Transplantation in Hodgkin Lymphoma
Cellular and Novel Immunotherapies for Classic Hodgkin Lym

Detalles del producto

Edición: 1
Última edición
Volumen: 40-2
Publicado: 23 de marzo de 2026
Idioma: Inglés

Sobre los editores

Alex F. Herrera

Afiliaciones y experiencia

Chief, Division of Lymphoma, Professor, Department of Hematology and Hematopoietic Cell Transplantation, Medical Director of the City of Hope Clinical Trials Office, Associate Medical Director of the Briskin Center for Clinical Research, City of Hope Medical Center, USA

Alison J. Moskowitz